| Dr David T Horio, MD | |
|
3320 Oahu Ave, Honolulu, HI 96822-1252 | |
| (808) 988-6229 | |
| Not Available |
| Full Name | Dr David T Horio |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 3320 Oahu Ave, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225197023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4171 (Hawaii) | Primary |
| Entity Name | Kapiolani Medical Center For Women & Children |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548215692 PECOS PAC ID: 9830097914 Enrollment ID: O20031229000149 |
News Archive
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marb-n, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Researchers in Cambodia, France, and the United States have conducted a study indicating that viruses related to SARS-CoV-2 – the agent that causes COVID-19 – are far more geographically widespread than previously thought.
A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.
Seema Tiwari-Woodruff, a professor of biomedical sciences in the School of Medicine at the University of California, Riverside, and her colleagues have received a grant of $373,000 from the National Multiple Sclerosis Society for a project in which her lab will select the five best candidate compounds to speed up nerve impulses, a promising new avenue to treat multiple sclerosis.
nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David T Horio, MD 3320 Oahu Ave, Honolulu, HI 96822-1252 Ph: () - | Dr David T Horio, MD 3320 Oahu Ave, Honolulu, HI 96822-1252 Ph: (808) 988-6229 |
News Archive
A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marb-n, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.
Researchers in Cambodia, France, and the United States have conducted a study indicating that viruses related to SARS-CoV-2 – the agent that causes COVID-19 – are far more geographically widespread than previously thought.
A drug formerly used to treat the skin disorder psoriasis has shown encouraging results in a phase 2 trial to assess its effectiveness in treating type 1 diabetes, according to new research published in The Lancet Diabetes & Endocrinology.
Seema Tiwari-Woodruff, a professor of biomedical sciences in the School of Medicine at the University of California, Riverside, and her colleagues have received a grant of $373,000 from the National Multiple Sclerosis Society for a project in which her lab will select the five best candidate compounds to speed up nerve impulses, a promising new avenue to treat multiple sclerosis.
nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.
› Verified 5 days ago
Stanley Y. Loo, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Sean Saito, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-295-6495 | |
Dr. Christopher Lum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Janira Marita Navarro Sanchez, MD Pathology Medicare: Medicare Enrolled Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-586-8212 | |
Dr. Karen S Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1309 Punahou St., Basement, Honolulu, HI 96826 Phone: 808-983-8581 Fax: 808-973-1401 | |
Dr. Kirk Hirata, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Gregory Kiyoshi Kobayashi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 347 N Kuakini St, Kuakini Medical Center, Honolulu, HI 96817 Phone: 808-547-9496 Fax: 808-547-9497 |